期刊文献+

中心性浆液性脉络膜视网膜病变治疗前后脉络膜厚度的短期观察 被引量:7

OCT-EDI characteristics of choroidal thickness shortly after treatment for acute central serous chorioretinopathy in patients
原文传递
导出
摘要 目的利用频域OCT的EDI(Enhanced depth imaging)技术观测急性中心性浆液性脉络膜视网膜病变(csc)患者经光动力治疗(PDT)或视网膜激光光凝治疗(LP)后脉络膜厚度的短期变化。方法回顾性病例对照研究。经最佳矫正视力(BCVA)、裂隙灯显微镜、前置镜、眼底照相,荧光素钠眼底血管造影(FFA)以及吲哚青绿血管造影(ICGA)等检查确诊为急性CSC的39例患者39眼纳入本研究。以FFA造影为标准,对于渗漏点位于黄斑中心凹无血管区(FAZ)内的患眼,行ICGA造影引导下的半剂量维速达尔PDT治疗;渗漏点位于FAZ外的患眼行LP治疗。在OCT-EDI模式下,取通过黄斑中心凹的水平、垂直两条单线扫描为测量线。以黄斑中心凹为圆心,1500μm为半径设定中心凹、下、上、鼻、颞共5个测量点。测量脉络膜厚度。治疗前后脉络膜厚度变化采用重复测量方差分析。结果经PDT治疗后,5处测量点的脉络膜厚度均较基线显著下降,差异有统计学意义;经LP治疗后,仅中心凹上、颞侧2处测量点脉络膜厚度较基线的下降具有统计学意义。结论PDT治疗作用于脉络膜血管,降低脉络膜高渗性,使黄斑区脉络膜厚度显著下降;LP治疗的作用靶点是RPE的渗漏点,脉络膜厚度仅在局部下降。 Objective To retrospectively evaluate choroidal thickness after treatment by photodynamic therapy (PDT) or laser photocoagulation (LP) in eyes with acute central serous chorioretinopathy (CSC) using enhanced depth imaging spectral-domain optical coherence tomography (EDI-OCT). Methods In this retrospective study, 39 eyes of 39 patients with idiopathic acute CSC were recruited, after the following comprehensive ocular examinations were performed: best-corrected visual acuity (BCVA), slit-lamp biomicroscopy, indirect ophthalmoscopy, fundus photography, fluorescein angiography (FFA), and indocyanine green angiography (ICGA). Patients were divided into 2 types based on FFA characteristics: points of leakage in the foveal avascular zone (FAZ) and points of leakage out from the FAZ. The first type, which is not amenable to LP, was treated with a half-dose of verteporfin PDT guided by ICGA, whereas the other type was treated with LP. Subfoveal ehoroidal thickness and choroidal thickness at 1500 p.m temporal, nasal, superior, and inferior to the fovea were measured. The choroidal thickness was measured with enhanced depth imaging OCT before treatment at baseline, and 1 and 3 months after treatment. The results of the choroidal thickness measurements were analyzed using a repeated measurement ANOVA. Results In the PDT group, choroidal thickness at all evaluating points had decreased significantly within 3 months compared to baseline. Whereas in the LP group, choroidal thickness had decreased significantly within 3 months only at 1500 txm superior and temporal to the fovea compared to baseline. Conclusion PDT reduces choroidal vascular hyperpermeability by remodeling the choroidal vascular system resulting in the reduction of ehoroidal thickness in the maeular region and may work by a different mechanism than LP, which targets RPE.
出处 《中华眼视光学与视觉科学杂志》 CAS 2013年第1期14-17,共4页 Chinese Journal Of Optometry Ophthalmology And Visual Science
基金 温州市科技计划资助项目(Y20100293)
关键词 体层摄影术 光学相干 中心性浆液性脉络膜视网膜病变 激光 光动力治疗 Tomography, optical coherence Central serous chorioretinopathy Laserphotocoagulation Photodynamic therapy
  • 相关文献

参考文献15

  • 1Klais CM, Ober MD, Ciardella AP, et al. Central serous chorioretinopathy. In Ryan SJ, ed-in-chief, Hinton DR, Schachat AP, Wilkinson CP, eds. Retina. 4th ed. vol. 2. Philadelphia: Elsevier Mosby, 2006:1135-1161.
  • 2Gass JD. Pathogenesis of disciform detachment of the neuro- epithelium. II. Idiopathic central serous choroidopathy. Am J Ophthalmol, 1967,63 : 587-615.
  • 3Piecolino FC, Borgia L. Central serous chorioretinopathy and indocyanine green angiography. Retina, 1994,14 : 231-42.
  • 4Iida T, Kishi S, Hagimura N, et al. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina, 1999,19:508-512.
  • 5刘晓玲,林冰,瞿佳.中心性浆液性脉络膜视网膜病变的吲哚青绿和荧光素眼底血管造影[J].中华眼底病杂志,2000,16(1):14-16. 被引量:30
  • 6Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol, 2008,146:496-500.
  • 7Pryds A, Larsen M. Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy. Acta Ophthalmol, 2011.doi : 10.1111/ j.1755-3768.2011.02157.x. [Epub ahead of print].
  • 8Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology, 2010,117 : 1792-1799.
  • 9Maruko I, Iida T, Sugano Y, et al. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy. Retina, 2011,31 : 1921-1927.
  • 10Chan WM, Lai TY, Lai RY, et al. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology, 2008,115 : 1756-1765.

二级参考文献27

  • 1毕燕龙,荣翱,李锦文.微脉冲激光治疗中心性浆液性脉络膜视网膜病变的临床疗效[J].中华眼底病杂志,2007,23(1):45-47. 被引量:8
  • 2Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium.Ⅱ. Idiopathic central serous choroidopathy. Am J Ophthalmol,1967,63:587- 615.
  • 3Jumper JM. Central serous chorioretinopathy. Br J Ophthalmol, 2003,87:663.
  • 4Baran NV, Gurlu VP, Esgin H. I.ong term macular function in eyes with central serous chorioretinopathy. Clin Experiment Ophthalmol, 2005,33 : 369-372.
  • 5Yap EY, Robertson DM. The long term outcome of central serous chorioretinopathy. Arch Ophthalmol, 1996,114 : 689-692.
  • 6Wang M, Munch IC, Hasler PW, et al. Central serous chorioretinopathy. Acta Ophthalmol, 2008,86 : 126-145.
  • 7Gilbert CM, Owens SL, Smith PD, et al. I.ong-term follow up of central serous chorioretinopathy. Br J Ophthalmol, 1984,68: 815- 820.
  • 8Castro-Correia J, Coutinho MF, Rosas V, et al. Long-term follow-up of central serous retinopathy in 150 patients. Doe Ophthalmol, 1992,81 : 379- 386.
  • 9Brancato R, Scialdone A, Peee A, et al. Eight-year follow up of central serous chorioretinopathy with and without laser treatment. Grades Arch Clin Exp Ophthalmol,1987,226:166- 168.
  • 10Otsuka S, Ohba N, Nakao K. A long-term follow-up study of severe variant of central serous ehorioretinopathy. Retina,2002, 22:25-32.

共引文献56

同被引文献117

  • 1王春燕,艾育德.近视性屈光不正中超声所示脉络膜厚度的变化[J].内蒙古医学杂志,2005,37(8):701-703. 被引量:4
  • 2刘昌东,陈文卫,郝力丹,周立明,冯惠兰.局部应用噻吗心安对人眼脉络膜血液循环的影响[J].中华眼底病杂志,1996,12(2):83-85. 被引量:1
  • 3黄叔仁.中心性浆液性脉络膜视网膜病变与浆液性视网膜色素上皮脱离//黄叔仁.眼底病诊断与治疗.北京:人民卫生出版社,2003:222-229.
  • 4葛坚.眼科学.2版.北京:人民卫生出版社,2010:327-349.
  • 5Cao J, Mcl.eod S, Merges CA, et al. Choriocapillaris degeneration and related pathologic changes in humarl diabetic eyes. Arch Ophthalmol, 1998,116 : 589 -597.
  • 6Spaide RF, Koizumi H, Pozonni MC. Enhanced depth imaging spectral domain optical coherence tomography. Am J Opht halmol, 2008,146 : 496-500.
  • 7Imamura Y, Fujiwara T, Margolis R, et al. Enhanced depth imaging of optical coherence tomography of the choroid in central serous chorioretinopathy. Retina, 2009,29 : 1469-1473.
  • 8Maruko I,Iida T, Sugano Y, el al. Subfoveal choroidal thickness aftet treatment of central serous ehorioretinopathy. Ophthalmology, 2010,117 : 1792-1799.
  • 9Margolis R,Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol, 2009,147 : 811-815.
  • 10Chnng SE, Kang SW, Lee HJ, et al. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age related macular degeneration. Ophthalmology, 2011,118 : 840 -845.

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部